Patents Assigned to 3100 Central Expressway LLC
  • Fused triazolo-pyrimidine compounds having useful pharmaceutical application
    Patent number: 11066410
    Abstract: A compound and/or a pharmaceutically acceptable salt thereof has the following formula A: These compounds can be PIKfyve kinase inhibitors.
    Type: Grant
    Filed: March 23, 2018
    Date of Patent: July 20, 2021
    Assignee: 3100 Central Expressway LLC
    Inventors: Sergei Romanov, Robert Greenhouse, Nikolai Sepetov